美國IMAXIO
IMAXIO 是一家專注于基因組學和疫苗領域的生物制藥公司。基因組學事業部的工作涉及人類健康領域中伴隨診斷測試開發的相關項目。IMAXIO 致力于獨立開發或與合作伙伴共同開發應用于人類和動物健康領域的重組疫苗。在法國,IMAXIO 已經推出了應對細螺旋體病的人體疫苗 Spirolept。
IMAXIO is a biopharmaceutical company specialized in the areas of genomics and vaccines. The genomic division is involved in programs for the development of companion and diagnostic tests in human health. IMAXIO is developing, both individually and with its partners, recombinant vaccines for applications in both human and animal health. In France, IMAXIO already markets Spirolept, a human vaccine against leptospirosis.